Related Experiment Video
Updated: Oct 12, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Role of NRF2 and Sirtuin activators in COVID-19
Hasnat Khan1, Shivangi Patel1, Anuradha Majumdar1
1Department of Pharmacology, Bombay College of Pharmacy, Mumbai 400098, India.
Abstract:
COVID-19 is a pandemic requiring immediate solution for treatment because of its complex pathophysiology. Exploration of novel targets and thus treatment will be life savers which is the need of the hour. 2 host factors- TMPRSS2 and ACE2 are responsible for the way the virus will enter and replicate in the host. Also NRF2 is an important protein responsible for its anti-inflammatory role by multiple mechanisms of action like inhibition of NF-kB, suppression of pro-inflammatory genes, etc. NRF2 is deacetylated by Sirtuins and therefore both have a direct association. Absence of SIRT indicates inhibition of NRF2 expression and thus no anti-oxidative and anti-inflammatory protection for the cell. Therefore, we propose that NRF2 activators and/or SIRT activators can be evaluated to check their efficacy in ameliorating the symptoms of COVID-19.
Insights
Investigating novel COVID-19 treatments, this study explores the roles of TMPRSS2, ACE2, NRF2, and Sirtuins. Activating NRF2 and SIRT pathways may offer new therapeutic strategies for ameliorating COVID-19 symptoms.
Area of Science:
- Molecular Biology
- Virology
- Immunology
Background:
- COVID-19 pathophysiology presents complex challenges requiring urgent therapeutic solutions.
- The virus entry and replication depend on host factors like TMPRSS2 and ACE2.
- NRF2 protein plays a crucial anti-inflammatory role by inhibiting NF-kB and suppressing pro-inflammatory genes.
Purpose of the Study:
- To explore novel therapeutic targets for COVID-19 treatment.
- To investigate the association between NRF2 and Sirtuins in the context of COVID-19.
- To propose NRF2 and/or SIRT activators as potential treatments for COVID-19.
Main Methods:
- Literature review on COVID-19 pathophysiology and host-pathogen interactions.
- Analysis of the molecular mechanisms involving NRF2, Sirtuins, TMPRSS2, and ACE2.
- Hypothesizing therapeutic potential based on known biological pathways.
Main Results:
- Sirtuins deacetylate NRF2, indicating a direct association between these proteins.
- Absence of SIRT leads to NRF2 inhibition, compromising anti-oxidative and anti-inflammatory cellular defenses.
- TMPRSS2 and ACE2 are key host factors for viral entry and replication.
Conclusions:
- NRF2 activators may enhance anti-inflammatory and anti-oxidative responses.
- SIRT activators could restore NRF2 function, offering cellular protection.
- Targeting NRF2 and SIRT pathways presents a promising avenue for COVID-19 therapeutic development.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of the Unfolded Protein Response
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Nitric Oxide Signaling Pathway
Regulation of Nuclear Protein Sorting

